Global Injectable Packaging Leader Maintains Performance Guidance Ahead of CEO Transition

West Pharmaceutical Services, Inc. (WST) announced on March 9 that Eric M. Green plans to step down from his roles as President, Chief Executive Officer, and Chairman of the Board upon the appointment of his successor. The board has engaged a global search firm to identify candidates, and the leadership transition is expected in the second half of 2026.

Along with this leadership announcement, West reconfirmed the 2026 performance guidance it issued on February 12. The company had projected 2026 annual revenue of approximately $3.2 billion to $3.3 billion (about KRW 4.2 trillion to KRW 4.3 trillion), forecasting mid-to-high single-digit growth. ()

West is a U.S. company that designs and manufactures packaging and drug delivery systems for injectable pharmaceuticals, including rubber stoppers, plastic containers, and wearable self-injection devices. A component of the S&P 500 Index, West is recognized as a leading provider of primary packaging materials and drug delivery solutions to global pharmaceutical and biotech firms amid the expansion of the biopharmaceutical and self-injection markets. ()